Explorer les evidences

96,6 %For cellular viral DNA, useful PR and RT sequences were obtained for 96.6% and 93.1% of the whole-blood-cell samples and for 93.1% and 93.1% of the DBS samples, respectively.

KenyaVIH/sidapublié 2007Journal of clinical microbiologyeurope_pmcdocument de 4 observations

13,3 %The mean proportion of follow-up covered by biomedical HIV prevention was 13.3% in the standard-of-care group.

KenyaVIH/sidapublié 2024The lancet. HIVPubMeddocument de 9 observations

34 %Among caregivers with untested children ≤12 years, 34% (166/483) of males and 89% (320/358) of females were eligible for index case testing for HIV.

KenyaVIH/sidapublié 2021Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 3 observations

72 %Missed opportunities for PrEP initiation were 72% among female sex workers (FSW).

KenyaVIH/sidaobservé February 2017 to December 2019publié 2020Journal of the International AIDS SocietyPubMeddocument de 13 observations

14 %Other infections were present in 22 (14%) of 162 HIV-attributed infant or child deaths.

Kenyaother infections · VIH/sidaobservé Dec 3, 2016 to Dec 31, 2024publié 2026The lancet. HIVPubMeddocument de 23 observations

Among adolescent girls in Kenya, sexual violence from intimate partners decreased between 2016/2017 and 2018.

KenyaVIH/sidaobservé 2016/2017, 2018publié 2022BMJ openPubMeddocument de 18 observations

The 3TC mutation M184V and the NNRTI mutation K103N were the most frequent resistance mutations observed.

KenyaVIH/sidapublié 2009AIDS research and therapyeurope_pmcdocument de 8 observations

1 300 000 inhabitantsThere were 1.3 million people living with HIV in Kenya.

KenyaVIH/sidapublié 2025BMC public healthPubMeddocument de 12 observations

61,2 %Among 651 (97.0%) participants who had ever been tested for HIV, 400 (61.2%) reported HIV testing in the past 6 months.

KenyaVIH/sidapublié 2021BMC public healthPubMeddocument de 8 observations

7 infectionsThere were seven incident HIV infections in 390 person-years of follow-up in the standard-of-care group.

KenyaVIH/sidapublié 2024The lancet. HIVPubMeddocument de 9 observations

1 700 000 individualsThere are approximately 1.7 million adolescents living with HIV globally.

KenyaVIH/sidapublié 2021Journal of the International AIDS SocietyPubMeddocument de 4 observations

12 %Of the male partners tested, 524 (12%) were newly diagnosed with HIV.

KenyaVIH/sidaobservé May 1, 2018 to March 31, 2020publié 2023The Lancet. Global healthPubMeddocument de 11 observations

6 %Mean predicted risk probability among pregnant and postpartum women with HIV with known HIV diagnosis was 6% in the low-risk quintile.

KenyaVIH/sidapublié 2025AIDS and behaviorPubMeddocument de 13 observations

18 US$The mean total unit cost of antiretroviral therapy (ART) was US$18 in Kenya.

KenyaVIH/sidaobservé 2019publié 2023BMC health services researchPubMeddocument de 11 observations

50 copies_per_mLIn the BREATHER Plus trial, participants had an HIV-1 viral load of less than 50 copies per mL over the previous 12 months.

KenyaVIH/sidaobservé previous 12 monthspublié 2026The lancet. HIVPubMeddocument de 10 observations

97,9 %In the APS+HIVST arm, 97.9% (2111/2157) of eligible partners were tested for HIV.

KenyaVIH/sidaobservé 2021publié 2024Journal of the International AIDS SocietyPubMeddocument de 15 observations

HIV vaccines studied in these trials had a low potential of induction of persisting HIV antibodies.

KenyaVIH/sidaobservé 2001-2007publié 2014Human vaccines & immunotherapeuticseurope_pmcdocument de 10 observationsDOI 10.4161/hv.27559

54 %Among children with HIV who underwent genotypic drug resistance testing in Kisumu County, Kenya, 54% had dual-class resistance.

KenyaVIH/sidaobservé March 2019 to December 2020publié 2023VirusesPubMeddocument de 8 observations

1,41 odds_ratioThe odds ratio for detection of vaginal HIV-1 RNA before versus during Trichomonas vaginalis infection was 1.41 (95% CI 0.23–8.79, p = 0.7).

KenyaVIH/sidapublié 2011BMC infectious diseaseseurope_pmcdocument de 5 observations

62 000 childrenAn estimated 62,000 children aged 0–14 years are living with HIV in Kenya.

KenyaVIH/sidaobservé 2024publié 2025AIDS research and therapyPubMeddocument de 6 observations

78 %78% of the adolescents and young adults living with HIV reported that disclosure positively influenced their antiretroviral therapy (ART) adherence.

KenyaVIH/sidaobservé 2019publié 2023Frontiers in public healthPubMeddocument de 18 observations

12,68 %Providing PrEP for all uninfected individuals identified through TMP averted up to 12.68% of new infections.

KenyaVIH/sidapublié 2023EpidemicsPubMeddocument de 7 observations

38,5 %Attrition at 12 months after enrollment among people living with HIV regardless of antiretroviral therapy status was 38.5% (95% CI 38.4–38.6).

KenyaVIH/sidapublié 2020PloS onePubMeddocument de 12 observations

29 %Among smear-positive pulmonary tuberculosis/HIV co-infected patients in Kenya between 2012 and 2015, 29% of women and 20% of men had HIV testing more than 3 months prior to TB treatment.

Kenyatuberculose · VIH/sidaobservé 2012-2015publié 2020PloS onePubMeddocument de 6 observations

97 %Of primary partners who were offered an HIV self-test, 97% accepted it.

KenyaVIH/sidapublié 2020Journal of the International AIDS SocietyPubMeddocument de 15 observations